Mayo Clinic researchers contribute to second phase of periphery nerve regeneration consortium

Researchers from the Mayo Clinic are focused on developing innovative periphery nerve regeneration to treat wounded veterans as part of the Armed Forces Institute of Regenerative Medicine consortium.

“The opportunity to work together with a multidisciplinary, multi-institutional team that will create new therapies for our injured service members is a privilege, and we are proud that Mayo Clinic will be able to make a contribution to this effort,” Anthony Windebank, MD, from the Mayo Clinic Center for Regenerative Medicine, stated in a press release.

Windebank will join Michael Yaszemski, MD, PhD, Allen Bishop, MD, and Alexander Shin, MD, as orthopedists from the Mayo Clinic in the second phase of the Armed Forces Institute of Regenerative Medicine (AFIRM-II) consortium.

In the first phase, researchers published clinical studies on new treatments for burns, scar reduction, face transplantation, minimally invasive surgery for craniofacial injuries, lower dose antirejection regimens after kidney transplantation and fat grafting for reconstruction surgery for a 5-year period.

AFIRM-II will seek ways to treat the health care challenges of wounded veterans from Iraq and Afghanistan. The $75 million, 5-year project will build on the efforts of the first phase to use regenerative medicine, like cell therapy, biomaterials engineering and transplants, to restore, replace, repair and regenerate tissues and organs.

Reference:
www.mayoclinic.org